Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice

Oncogene

Volumn 18, Issue 47, 1999, Pages 6597-6604

  Murphy, Kristen L ^a   Kittrell, Frances S ^a   Gay, Jason P ^a   Jäger, Richard ^b   Medina, Daniel ^a   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Bcl 2; DMBA; Mammary tumorigenesis; Transgenic mice

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR MODEL;

ANIMALIA; MUS MUSCULUS;

EID: 0033547304     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203099     Document Type: Article

References (23)

1. Beham A, Marin MC, Fernandez A, Herrmann J, Brisbay S, Tari AM, Lopez-Berestein G, Lozano G, Sarkiss M and McDonnell TJ. (1997). Oncogene, 15, 2767-2772.
2. Borner C. (1996). J. Biol. Chem., 271, 12695-12698.
3. Christov K, Swanson SM, Guzman RC, Thordarson G, Jin E, Talamantes F and Nandi S. (1993). Carcinogenesis, 14, 2019-2025.
4. Friedrich K, Dimmer V, Haroske G, Lossnitzer A, Kasper M, Theissig F and Kunze KD. (1995). Path. Res. Pract., 191, 1114-1121.
5. Gavrieli Y, Sherman Y and Ben-Sasson SA. (1992). J. Cell Biol. 119, 493-501.
6. Hermeking H and Eick D. (1994). Science, 265, 2091-2093.
7. Humphreys RC, Krajewska M, Krnacik S, Jaeger R, Weiher H, Krajewski S, Reed JC and Rosen JM. (1996). Development, 122, 4013-4022.
8. Jäger R, Herzer U, Schenkel J and Weiher H. (1997). Oncogene. 15, 1787-1795.
9. Kroemer G. (1997). Nature Med., 3, 614-620.
10. Li B, Greenberg N, Stephens LC, Meyn R, Medina D and Rosen JM. (1994). Cell Growth Differ, 5, 711-721.
11. Li B, Kittrell FS, Medina D and Rosen JM. (1995). Mol. Carcinog., 14, 75-83.
12. Lu PJ, Lu QL, Rughetti A and Taylor-Papadimitriou J. (1995). J. Cell Biol., 129, 1363-1378.
13. Luna-More S, de los Santos F, Breton JJ and Canadas MA. (1996). Path. Res. Pract., 192, 27-32.
14. Marin MC, Hsu B, Meyn RE, Donehower LA, El-Naggar AK and McDonnell TJ. (1994). Oncogene, 9, 3107-3112.
15. Medina D. (1974). J. Natl. Cancer Inst., 53, 213-217.
16. Merlo GR, Cell N and Hynes NE. (1997). Cell Growth Differ, 8, 251-260.
17. Naumovski L and Cleary ML. (1996). Mol. Cell. Biol., 16, 3884-3892.
18. O'Reilly LA, Huang DCS and Strasser A. (1996). EMBO J., 15, 6979-6990.
19. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 3714-3717.
20. Rodriguez-Villanueva J, Greenhalgh D, Wang X-J, Bundman D, Cho S, Delehedde M. Roop D and McDonnell TJ. (1998). Oncogene, 16, 853-863.
21. Siziopikou KP, Prioleau JE, Harris JR and Schnitt SJ. (1996). Cancer, 77, 499-506.
22. Strasser A, Harris AW, Jacks T and Cory S. (1994). Cell. 79, 329-339.
23. Teixeira C, Reed JC and Pratt MA. (1995). Cancer Res., 55, 3902-3907.